Cheryl L. Marker, Ph.D. - Publications

Affiliations: 
2005 University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Pharmacology, Neuroscience Biology

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Crouse B, Miller SM, Muelken P, Hicks L, Vigliaturo JR, Marker CL, Guedes AGP, Pentel PR, Evans JT, LeSage MG, Pravetoni M. A TLR7/8 agonist increases efficacy of anti-fentanyl vaccines in rodent and porcine models. Npj Vaccines. 8: 107. PMID 37488109 DOI: 10.1038/s41541-023-00697-9  0.573
2023 Triller G, Vlachou EP, Hashemi H, van Straaten M, Zeelen JP, Kelemen Y, Baehr C, Marker CL, Ruf S, Svirina A, Chandra M, Urban K, Gkeka A, Kruse S, Baumann A, et al. A trypanosome-derived immunotherapeutics platform elicits potent high-affinity antibodies, negating the effects of the synthetic opioid fentanyl. Cell Reports. 42: 112049. PMID 36719797 DOI: 10.1016/j.celrep.2023.112049  0.547
2022 Hamid FA, Marker CL, Raleigh MD, Khaimraj A, Winston S, Pentel PR, Pravetoni M. Pre-clinical safety and toxicology profile of a candidate vaccine to treat oxycodone use disorder. Vaccine. 40: 3244-3252. PMID 35469698 DOI: 10.1016/j.vaccine.2022.03.053  0.547
2008 Smith SB, Marker CL, Perry C, Liao G, Sotocinal SG, Austin JS, Melmed K, Clark JD, Peltz G, Wickman K, Mogil JS. Quantitative trait locus and computational mapping identifies Kcnj9 (GIRK3) as a candidate gene affecting analgesia from multiple drug classes. Pharmacogenetics and Genomics. 18: 231-41. PMID 18300945 DOI: 10.1097/Fpc.0B013E3282F55Ab2  0.632
2006 Marker CL, Luján R, Colón J, Wickman K. Distinct populations of spinal cord lamina II interneurons expressing G-protein-gated potassium channels. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 12251-9. PMID 17122050 DOI: 10.1523/Jneurosci.3693-06.2006  0.608
2006 Kulik A, Vida I, Fukazawa Y, Guetg N, Kasugai Y, Marker CL, Rigato F, Bettler B, Wickman K, Frotscher M, Shigemoto R. Compartment-dependent colocalization of Kir3.2-containing K+ channels and GABAB receptors in hippocampal pyramidal cells. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 4289-97. PMID 16624949 DOI: 10.1523/Jneurosci.4178-05.2006  0.592
2005 Marker CL, Luján R, Loh HH, Wickman K. Spinal G-protein-gated potassium channels contribute in a dose-dependent manner to the analgesic effect of mu- and delta- but not kappa-opioids. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 3551-9. PMID 15814785 DOI: 10.1523/Jneurosci.4899-04.2005  0.637
2004 Marker CL, Stoffel M, Wickman K. Spinal G-protein-gated K+ channels formed by GIRK1 and GIRK2 subunits modulate thermal nociception and contribute to morphine analgesia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 2806-12. PMID 15028774 DOI: 10.1523/Jneurosci.5251-03.2004  0.647
2002 Marker CL, Cintora SC, Roman MI, Stoffel M, Wickman K. Hyperalgesia and blunted morphine analgesia in G protein-gated potassium channel subunit knockout mice. Neuroreport. 13: 2509-13. PMID 12499858 DOI: 10.1097/00001756-200212200-00026  0.646
2002 Bettahi I, Marker CL, Roman MI, Wickman K. Contribution of the Kir3.1 subunit to the muscarinic-gated atrial potassium channel IKACh. The Journal of Biological Chemistry. 277: 48282-8. PMID 12374786 DOI: 10.1074/Jbc.M209599200  0.621
2002 Torrecilla M, Marker CL, Cintora SC, Stoffel M, Williams JT, Wickman K. G-protein-gated potassium channels containing Kir3.2 and Kir3.3 subunits mediate the acute inhibitory effects of opioids on locus ceruleus neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 4328-34. PMID 12040038 DOI: 10.1523/Jneurosci.22-11-04328.2002  0.63
Show low-probability matches.